EndoT formulation developed by cellter provides the first nano drug that triggers vascular regeneration.
It is based on a bioengineered nano drug that leads and increases mobilization of stem cells from the bone marrow to the peripheric blood.
The use of our product will decrease the risks of vascular and cardiovascular diseases, improve the apheresis treatments by increasing the stem cell recovery and reducing the time necessary to achieve oncological and tissue regenerative therapies.
Our effective cost of production will allow us to deliver stem cell mobilization therapies to an unprecedented range of pathologies to a wide range of patients.
EndOX formulation developed by cellter provides the first nano drug that triggers cellular antioxidative processes improving cell homeostasis and vascular regeneration.
It is based on a bioengineered nano drug that triggers increased antioxidative processes over targeted cells.
The use of our product will decrease the rate of injuries in healthy tissues and improve the treatment of the injured ones. It will improve apheresis treatments by providing an enhanced microenvironment for stem cells implant in the damaged tissue reducing the time necessary to achieve oncological and tissue regenerative processes.
Our improved cost of production will allow us to deliver next-generation antioxidative cell therapies.
cellter employs Node our cutting-edge software created with Artificial Intelligence and trained with Machine Learning algorithms that perform a rational, intensely iterative approach to drug discovery and development while performing a clinical insight throughout the process to identify and solve the greatest patient and clinical needs.
Node takes market insights to deliver the most efficient development pathways and the best commercial opportunities to increase the chance of seeing our disrupting medicines being delivered to the patients.
The result is a prolific and sustainable discovery engine of potent and specific Nanopharmaceutical drug candidates, that has already produced breakthrough nano drugs agents for the potential treatment of Cardiovascular Diseases, Cancer, and general tissue regeneration.